Skip to main content

Table 2 Pathogenic variants identified in this study

From: Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: the Italian experience from the ‘beyond epilepsy’ project

ID

Sex

Gene

Genomic position

(hg19)

cDNA

Change

Protein

Change

Effect

Status

GERP

Mutation Taster

SIFT

CADD

Inferred effect

(ACMG)

2

F

MECP2

X:153296096

NM_004992.3

c.1157_1186delinsA

p.(Leu386Hisfs*9)

Frameshift

HET

5.49

Disease causing

Likely pathogenic

12

F

MECP2

X:153296882

NM_004992.3

c.397C > T

p.(Arg133Cys)

Missense

HET

5.24

Disease causing

Damaging

34

Pathogenic

13

F

MECP2

X:153296777

NM_004992.3

c.502C > T

p.(Arg168*)

Stop gained

HET

5.48

Disease causing

Damaging

38

Pathogenic

21

F

TPP1

11:6638385

NM_000391.3

c.509-1G > C

Altered acceptor site

(HSF)

HOM

4.43

Disease causing

31

Pathogenic

  1. ACMG American College of Medical Genetics and Genomics, CADD Combined Annotation Dependent Depletion, F female, GERP Genomic Evolutionary Rate Profiling, HET heterozygous, HOM homozygous, HSF Human Splice Finder, SIFT Sorting Intolerant From Tolerant, XL X-linked